Enavate Sciences GP, LLC
- SEC CIK
- 0001953107
- Latest filing
- Aug 14, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 6
- 0 vs. Q1 2025
- Portfolio value
- $176.5M
- +$43.8M (+33.0%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| IMNMImmunome Inc. | COM | 4,768,583 | $44.3M | 25.1% | 00.0% | Unchanged | History |
| SIONSionna Therapeutics, Inc. | COM | 2,478,030 | $43.0M | 24.4% | 00.0% | Unchanged | History |
| ZBIOZenas BioPharma, Inc. | COM | 3,761,359 | $36.4M | 20.6% | 00.0% | Unchanged | History |
| UPBUpstream Bio, Inc. | COM | 2,459,703 | $27.0M | 15.3% | 00.0% | Unchanged | History |
| CMPXCompass Therapeutics, Inc. | COM | 7,788,150 | $20.2M | 11.5% | 00.0% | Unchanged | History |
| CAMPCamp4 Therapeutics Corp | COM | 3,785,802 | $5.49M | 3.1% | 00.0% | Unchanged | History |